Emma Morrish
Parkville, VIC 3010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
Journal: European journal of immunology
Published: August 22, 2022
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.
Journal: Nature cancer
Published: August 22, 2022
Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death.
Journal: Science advances
Published: May 11, 2022
Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy.
Journal: Signal transduction and targeted therapy
Published: May 10, 2022
Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms.
Journal: Nature communications
Published: April 22, 2021
MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia.
Journal: Blood advances
Published: June 19, 2020
Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 16, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026